Fri Sep 20 14:17:24 UTC 2024: ## Hedge Fund Cuts Lam Research Stake, Others Pile In: LRCX Stock Sees Mixed Signals

**San Francisco, CA – September 20, 2024** – Lam Research (NASDAQ:LRCX) saw a mixed bag of activity from institutional investors in the second quarter, with one hedge fund significantly reducing its stake while others increased their holdings.

SYSTM Wealth Solutions LLC slashed its position in Lam Research by a massive 95.5%, selling off 1,008 shares, leaving them with just 47 shares worth approximately $50,000. This move comes in stark contrast to other investors.

Cypress Capital Group boosted its stake in Lam Research by 23.1%, acquiring 661 additional shares and now holding 3,528 shares valued at $3,757,000. Similarly, Meeder Advisory Services Inc. saw a 29.4% increase in their holdings, purchasing 686 shares and currently owning 3,022 shares worth $3,218,000.

Brookstone Capital Management and FineMark National Bank & Trust also added to their positions, increasing their stakes by 142.6% and 14.5%, respectively. Foundations Investment Advisors LLC displayed the most significant confidence in the company, boosting its stake by a whopping 534.3%.

Overall, institutional investors and hedge funds now own 84.61% of Lam Research stock.

Despite the mixed signals from institutional investors, Lam Research continues to perform well. The company reported strong second-quarter earnings, beating analysts’ expectations with $8.14 earnings per share. Revenue also exceeded predictions, reaching $3.87 billion. The company also announced a quarterly dividend increase, pushing the annualized dividend to $9.20, representing a 1.17% yield.

However, recent insider selling activity might raise concerns among some investors. CAO Christina Correia sold 647 shares and CEO Timothy Archer sold 9,650 shares in separate transactions, potentially signaling a lack of confidence in the company’s future prospects.

Several analysts have weighed in on Lam Research stock, with a mix of “buy” and “hold” ratings. While Citigroup lowered its price target, Needham & Company LLC and TD Cowen maintained their “buy” ratings and increased their price objectives. MarketBeat.com currently assigns a “Moderate Buy” rating to LRCX with a consensus target price of $1,013.37.

Lam Research’s future remains uncertain, with the company facing challenges in the semiconductor industry. The mixed signals from investors and insider selling activity create an intriguing situation, highlighting the potential risks and rewards associated with this stock.

Read More